{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:14:54Z","timestamp":1794507294012,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chongqing YuZhong Science Project","award":["20170127"],"award-info":[{"award-number":["20170127"]}]},{"name":"clinical research of Chinese Medical Association","award":["17020430712, 17020430713"],"award-info":[{"award-number":["17020430712, 17020430713"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Many studies have demonstrated the benefits of the addition of growth hormone (GH) to the controlled ovarian stimulation protocol in vitro fertilization (IVF) cycles in poor-respond patients, but the effect of GH on patients with poor embryonic development remain unclear. This paper was designed to investigate the efficacy of GH co-treatment during IVF for the patients with poor embryonic development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>A randomized controlled trial including 158 patients with poor embryo development was conducted between July 2017 and February 2019. One hundred and seven patients were randomized for GH treatment (GH group) and 51 patients for untreated (control group). The primary end-points were the clinical pregnancy and live birth rates in the two groups. The oocyte competence were assessed through calculating the mitochondrial DNA (mtDNA) copy number in corresponding cumulus granulosa cells (CGCs). Quantitative PCR were used for calculation of mtDNA copy number.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Relative to the control group, GH co-treatment resulted in a significantly higher number of retrieved oocytes (10.29\u2009\u00b1\u20095.92 versus 8.16\u2009\u00b1\u20094.17, <jats:italic>P<\/jats:italic>\u2009=\u20090.023) and cleaved embryos (6.73\u2009\u00b1\u20094.25 versus 5.29\u2009\u00b1\u20093.23, <jats:italic>P<\/jats:italic>\u2009=\u20090.036). The implantation rate, clinical pregnancy rates per cycle, and live birth rate per cycle were higher in the GH group than in the control group (36.00% versus 17.86%, <jats:italic>P<\/jats:italic>\u2009=\u20090.005; 43.93% versus 19.61%, <jats:italic>P<\/jats:italic>\u2009=\u20090.005; 41.12% versus 17.65%, <jats:italic>P<\/jats:italic>\u2009=\u20090.006). CGCs of the GH group had significantly higher mtDNA copy numbers than CGCs of the control group (252 versus 204, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These data provided further evidence to indicate that GH supplementation may support more live births during IVF, in patients with poor embryonic development. It also appears that oocytes generated under GH co-treatment have a better developmental competence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=36045\">ChiCTR1900021992<\/jats:ext-link> posted March 19, 2019 (retrospectively registered).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-020-03004-9","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T06:02:57Z","timestamp":1589954577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"given":"Jingyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"issue":"7","key":"3004_CR1","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/humrep\/deu079","volume":"29","author":"G Oron","year":"2014","unstructured":"Oron G, Son WY, Buckett W, Tulandi T, Holzer H. The association between embryo quality and perinatal outcome of singletons born after single embryo transfers: a pilot study. Hum Reprod. 2014;29(7):1444\u201351.","journal-title":"Hum Reprod"},{"issue":"12","key":"3004_CR2","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s10815-014-0351-8","volume":"31","author":"J Zhu","year":"2014","unstructured":"Zhu J, Lian Y, Li M, Chen L, Liu P, Qiao J. Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? J Assist Reprod Genet. 2014;31(12):1635\u201341.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"3004_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nsmb.2660","volume":"20","author":"L Yan","year":"2013","unstructured":"Yan L, Yang M, Guo H, Yang L, Wu J, Li R, et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013;20(9):1131\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"7464","key":"3004_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nature12364","volume":"500","author":"Z Xue","year":"2013","unstructured":"Xue Z, Huang K, Cai C, Cai L, Jiang CY, Feng Y, et al. Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing. Nature. 2013;500(7464):593\u20137.","journal-title":"Nature"},{"issue":"2","key":"3004_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0303-7207(01)00683-9","volume":"186","author":"RG Gosden","year":"2002","unstructured":"Gosden RG. Oogenesis as a foundation for embryogenesis. Mol Cell Endocrinol. 2002;186(2):149\u201353.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"3004_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/humupd\/dmn025","volume":"14","author":"JE Swain","year":"2008","unstructured":"Swain JE, Pool TB. ART failure: oocyte contributions to unsuccessful fertilization. Hum Reprod Update. 2008;14(5):431\u201346.","journal-title":"Hum Reprod Update"},{"issue":"1\u20132","key":"3004_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0303-7207(99)00238-5","volume":"163","author":"MJ Faddy","year":"2000","unstructured":"Faddy MJ. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol. 2000;163(1\u20132):43\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"13 Suppl","key":"3004_CR8","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.2527\/jas.2006-432","volume":"85","author":"AJ Watson","year":"2007","unstructured":"Watson AJ. Oocyte cytoplasmic maturation: a key mediator of oocyte and embryo developmental competence. J Anim Sci. 2007;85(13 Suppl):E1\u20133.","journal-title":"J Anim Sci"},{"issue":"41","key":"3004_CR9","doi-asserted-by":"publisher","first-page":"17639","DOI":"10.1073\/pnas.1013185107","volume":"107","author":"S Wang","year":"2010","unstructured":"Wang S, Kou Z, Jing Z, Zhang Y, Guo X, Dong M, et al. Proteome of mouse oocytes at different developmental stages. Proc Natl Acad Sci U S A. 2010;107(41):17639\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3004_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/GCO.0000000000000164","volume":"27","author":"E Babayev","year":"2015","unstructured":"Babayev E, Seli E. Oocyte mitochondrial function and reproduction. Curr Opin Obstet Gynecol. 2015;27(3):175\u201381.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"3004_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/humupd\/dmq029","volume":"17","author":"L Rienzi","year":"2011","unstructured":"Rienzi L, Vajta G, Ubaldi F. Predictive value of oocyte morphology in human IVF: a systematic review of the literature. Hum Reprod Update. 2011;17(1):34\u201345.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"3004_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1472-6483(10)61187-X","volume":"12","author":"B Balaban","year":"2006","unstructured":"Balaban B, Urman B. Effect of oocyte morphology on embryo development and implantation. Reprod BioMed Online. 2006;12(5):608\u201315.","journal-title":"Reprod BioMed Online"},{"issue":"8","key":"3004_CR13","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1093\/humrep\/des170","volume":"27","author":"E Fragouli","year":"2012","unstructured":"Fragouli E, Wells D, Iager AE, Kayisli UA, Patrizio P. Alteration of gene expression in human cumulus cells as a potential indicator of oocyte aneuploidy. Hum Reprod. 2012;27(8):2559\u201368.","journal-title":"Hum Reprod"},{"issue":"11","key":"3004_CR14","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1093\/humrep\/det357","volume":"28","author":"J Ekart","year":"2013","unstructured":"Ekart J, McNatty K, Hutton J, Pitman J. Ranking and selection of MII oocytes in human ICSI cycles using gene expression levels from associated cumulus cells. Hum Reprod. 2013;28(11):2930\u201342.","journal-title":"Hum Reprod"},{"issue":"3","key":"3004_CR15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.fertnstert.2012.10.041","volume":"99","author":"AE Iager","year":"2013","unstructured":"Iager AE, Kocabas AM, Otu HH, Ruppel P, Langerveld A, Schnarr P, et al. Identification of a novel gene set in human cumulus cells predictive of an oocyte\u2019s pregnancy potential. Fertil Steril. 2013;99(3):745\u201352 e6.","journal-title":"Fertil Steril"},{"key":"3004_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fertnstert.2018.09.016","volume":"111","author":"MC Magli","year":"2018","unstructured":"Magli MC, Albanese C, Crippa A, Tabanelli C, Ferraretti AP, Gianaroli L. Deoxyribonucleic acid detection in blastocoelic fluid: a new predictor of embryo ploidy and viable pregnancy. Fertil Steril. 2018;111:77\u201385.","journal-title":"Fertil Steril"},{"issue":"9","key":"3004_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s10815-011-9588-7","volume":"28","author":"Y Bentov","year":"2011","unstructured":"Bentov Y, Yavorska T, Esfandiari N, Jurisicova A, Casper RF. The contribution of mitochondrial function to reproductive aging. J Assist Reprod Genet. 2011;28(9):773\u201383.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"3004_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.fertnstert.2005.09.017","volume":"85","author":"TA Santos","year":"2006","unstructured":"Santos TA, El Shourbagy S, St John JC. Mitochondrial content reflects oocyte variability and fertilization outcome. Fertil Steril. 2006;85(3):584\u201391.","journal-title":"Fertil Steril"},{"issue":"5","key":"3004_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/molehr\/7.5.425","volume":"7","author":"P Reynier","year":"2001","unstructured":"Reynier P, May-Panloup P, Chretien MF, Morgan CJ, Jean M, Savagner F, et al. Mitochondrial DNA content affects the fertilizability of human oocytes. Mol Hum Reprod. 2001;7(5):425\u20139.","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"3004_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/mrd.22042","volume":"79","author":"H Ge","year":"2012","unstructured":"Ge H, Tollner TL, Hu Z, Dai M, Li X, Guan H, et al. The importance of mitochondrial metabolic activity and mitochondrial DNA replication during oocyte maturation in vitro on oocyte quality and subsequent embryo developmental competence. Mol Reprod Dev. 2012;79(6):392\u2013401.","journal-title":"Mol Reprod Dev"},{"issue":"2","key":"3004_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/oxfordjournals.humrep.a135954","volume":"10","author":"J Van Blerkom","year":"1995","unstructured":"Van Blerkom J, Davis PW, Lee J. ATP content of human oocytes and developmental potential and outcome after in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10(2):415\u201324.","journal-title":"Hum Reprod"},{"issue":"3","key":"3004_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/humrep\/deh667","volume":"20","author":"P May-Panloup","year":"2005","unstructured":"May-Panloup P, Chretien MF, Jacques C, Vasseur C, Malthiery Y, Reynier P. Low oocyte mitochondrial DNA content in ovarian insufficiency. Hum Reprod. 2005;20(3):593\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"3004_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10815-015-0621-0","volume":"33","author":"M Ogino","year":"2016","unstructured":"Ogino M, Tsubamoto H, Sakata K, Oohama N, Hayakawa H, Kojima T, et al. Mitochondrial DNA copy number in cumulus cells is a strong predictor of obtaining good-quality embryos after IVF. J Assist Reprod Genet. 2016;33(3):367\u201371.","journal-title":"J Assist Reprod Genet"},{"key":"3004_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10815-018-1348-5","volume":"36","author":"A Taugourdeau","year":"2018","unstructured":"Taugourdeau A, Desquiret-Dumas V, Hamel JF, Chupin S, Boucret L, Ferre-L\u2019hotellier V, et al. The mitochondrial DNA content of cumulus cells may help predict embryo implantation. J Assist Reprod Genet. 2018;36:223\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"3004_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1210\/en.2011-1646","volume":"153","author":"E Nakamura","year":"2012","unstructured":"Nakamura E, Otsuka F, Inagaki K, Miyoshi T, Matsumoto Y, Ogura K, et al. Mutual regulation of growth hormone and bone morphogenetic protein system in steroidogenesis by rat granulosa cells. Endocrinology. 2012;153(1):469\u201380.","journal-title":"Endocrinology"},{"issue":"10","key":"3004_CR26","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1210\/en.2002-220087","volume":"143","author":"A Bachelot","year":"2002","unstructured":"Bachelot A, Monget P, Imbert-Bollore P, Coshigano K, Kopchick JJ, Kelly PA, et al. Growth hormone is required for ovarian follicular growth. Endocrinology. 2002;143(10):4104\u201312.","journal-title":"Endocrinology"},{"issue":"1\u20132","key":"3004_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0303-7207(02)00270-8","volume":"197","author":"MM Bevers","year":"2002","unstructured":"Bevers MM, Izadyar F. Role of growth hormone and growth hormone receptor in oocyte maturation. Mol Cell Endocrinol. 2002;197(1\u20132):173\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"3004_CR28","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/HUMREP\/10.6.1341","volume":"10","author":"S Pellegrini","year":"1995","unstructured":"Pellegrini S, Fuzzi B, Pratesi S, Mannelli M, Criscuoli L, Messeri G, et al. In-vivo studies on ovarian insulin-like growth factor I concentrations in human preovulatory follicles and human ovarian circulation. Hum Reprod. 1995;10(6):1341\u20135.","journal-title":"Hum Reprod"},{"issue":"2","key":"3004_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/humrep\/13.2.285","volume":"13","author":"GJ Oosterhuis","year":"1998","unstructured":"Oosterhuis GJ, Vermes I, Lambalk CB, Michgelsen HW, Schoemaker J. Insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in fluid from human stimulated follicles. Hum Reprod. 1998;13(2):285\u20139.","journal-title":"Hum Reprod"},{"issue":"4","key":"3004_CR30","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/humrep\/17.4.1017","volume":"17","author":"C Mendoza","year":"2002","unstructured":"Mendoza C, Ruiz-Requena E, Ortega E, Cremades N, Martinez F, Bernabeu R, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002;17(4):1017\u201322.","journal-title":"Hum Reprod"},{"issue":"3","key":"3004_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/humrep\/14.3.628","volume":"14","author":"C Mendoza","year":"1999","unstructured":"Mendoza C, Cremades N, Ruiz-Requena E, Martinez F, Ortega E, Bernabeu S, et al. Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod. 1999;14(3):628\u201335.","journal-title":"Hum Reprod"},{"issue":"4","key":"3004_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/(SICI)1098-2795(199908)53:4<398::AID-MRD5>3.0.CO;2-I","volume":"53","author":"F Izadyar","year":"1999","unstructured":"Izadyar F, Zhao J, Van Tol HT, Colenbrander B, Bevers MM. Messenger RNA expression and protein localization of growth hormone in bovine ovarian tissue and in cumulus oocyte complexes (COCs) during in vitro maturation. Mol Reprod Dev. 1999;53(4):398\u2013406.","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"3004_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","volume":"25","author":"T Kucuk","year":"2008","unstructured":"Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet. 2008;25(4):123\u20137.","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"3004_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.rbmo.2010.03.013","volume":"21","author":"JL Yovich","year":"2010","unstructured":"Yovich JL, Stanger JD. Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF. Reprod BioMed Online. 2010;21(1):37\u201349.","journal-title":"Reprod BioMed Online"},{"issue":"10","key":"3004_CR35","doi-asserted-by":"publisher","first-page":"e018107","DOI":"10.1136\/bmjopen-2017-018107","volume":"7","author":"KN Keane","year":"2017","unstructured":"Keane KN, Yovich JL, Hamidi A, Hinchliffe PM, Dhaliwal SS. Single-Centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis. BMJ Open. 2017;7(10):e018107.","journal-title":"BMJ Open"},{"key":"3004_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fendo.2018.00014","volume":"9","author":"KN Keane","year":"2018","unstructured":"Keane KN, Hinchliffe PM, Rowlands PK, Borude G, Srinivasan S, Dhaliwal SS, et al. DHEA supplementation confers no additional benefit to that of growth hormone on pregnancy and live birth rates in IVF patients categorized as poor prognosis. Front Endocrinol. 2018;9:14.","journal-title":"Front Endocrinol"},{"issue":"5","key":"3004_CR37","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S1472-6483(10)60011-9","volume":"18","author":"A Hazout","year":"2009","unstructured":"Hazout A, Junca A, Menezo Y, Demouzon J, Cohen-Bacrie P. Effect of growth hormone on oocyte competence in patients with multiple IVF failures. Reprod BioMed Online. 2009;18(5):664\u201370.","journal-title":"Reprod BioMed Online"},{"issue":"3","key":"3004_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","volume":"105","author":"YA Bassiouny","year":"2016","unstructured":"Bassiouny YA, Dakhly DMR, Bayoumi YA, Hashish NM. Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril. 2016;105(3):697\u2013702.","journal-title":"Fertil Steril"},{"issue":"2","key":"3004_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/REP-14-0494","volume":"149","author":"BM Weall","year":"2015","unstructured":"Weall BM, Al-Samerria S, Conceicao J, Yovich JL, Almahbobi G. A direct action for GH in improvement of oocyte quality in poor-responder patients. Reproduction. 2015;149(2):147\u201354.","journal-title":"Reproduction"},{"issue":"4","key":"3004_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/REP-18-0529","volume":"157","author":"HY Hou","year":"2018","unstructured":"Hou HY, Wang X, Yu Q, Li HY, Li SJ, Tang RY, et al. Evidence that growth hormone can improve mitochondrial function in oocytes from aged mice. Reproduction. 2018;157(4):345\u201358.","journal-title":"Reproduction"},{"issue":"6","key":"3004_CR41","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/humupd\/dmp026","volume":"15","author":"EM Kolibianakis","year":"2009","unstructured":"Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(6):613\u201322.","journal-title":"Hum Reprod Update"},{"key":"3004_CR42","first-page":"CD000099","volume":"1","author":"JM Duffy","year":"2010","unstructured":"Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2010;1:CD000099.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3004_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/0974-1208.183515","volume":"9","author":"YB Jeve","year":"2016","unstructured":"Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: a systematic review and meta-analysis. J Hum Reprod Sci. 2016;9(2):70\u201381.","journal-title":"J Hum Reprod Sci"},{"issue":"7","key":"3004_CR44","first-page":"565","volume":"31","author":"K Lattes","year":"2015","unstructured":"Lattes K, Brassesco M, Gomez M, Checa MA. Low-dose growth hormone supplementation increases clinical pregnancy rate in poor responders undergoing in vitro fertilisation. Gynecol Endocrinol. 2015;31(7):565\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"3004_CR45","first-page":"4954","volume":"8","author":"X Yu","year":"2015","unstructured":"Yu X, Ruan J, He LP, Hu W, Xu Q, Tang J, et al. Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis. Int J Clin Exp Med. 2015;8(4):4954\u201367.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"3004_CR46","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","volume":"287","author":"M Eftekhar","year":"2013","unstructured":"Eftekhar M, Aflatoonian A, Mohammadian F, Eftekhar T. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet. 2013;287(5):1017\u201321.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"3004_CR47","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0015-0282(16)58217-X","volume":"65","author":"A Suikkari","year":"1996","unstructured":"Suikkari A, MacLachlan V, Koistinen R, Seppala M, Healy D. Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology. Fertil Steril. 1996;65(4):800\u20135.","journal-title":"Fertil Steril"},{"issue":"1","key":"3004_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.stem.2016.10.001","volume":"20","author":"H Ma","year":"2017","unstructured":"Ma H, O'Neil RC, Marti Gutierrez N, Hariharan M, Zhang ZZ, He Y, et al. Functional human oocytes generated by transfer of polar body genomes. Cell Stem Cell. 2017;20(1):112\u20139.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"3004_CR49","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10815-011-9630-9","volume":"28","author":"S Xiong","year":"2011","unstructured":"Xiong S, Han W, Liu JX, Zhang XD, Liu WW, Liu H, et al. Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF. J Assist Reprod Genet. 2011;28(12):1205\u201311.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3004_CR50","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive M, Embryology ESIGo","year":"2011","unstructured":"Alpha Scientists in Reproductive M, Embryology ESIGo. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26(6):1270\u201383.","journal-title":"Hum Reprod"},{"issue":"3","key":"3004_CR51","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/GCO.0000000000000360","volume":"29","author":"RJ Hart","year":"2017","unstructured":"Hart RJ, Rombauts L, Norman RJ. Growth hormone in IVF cycles: any hope? Curr Opin Obstet Gynecol. 2017;29(3):119\u201325.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"5","key":"3004_CR52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0015-0282(16)57902-3","volume":"64","author":"HS Jacobs","year":"1995","unstructured":"Jacobs HS, Shoham Z, Schachter M, Braat DD, Hamiltongairley D, Gillingsmith CM, Hull MG, Burger HG, Healy DL, Coutts JR, Fleming R. Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: a prospective, randomized, placebo-controlled, dose-response study. European and Australian Multicenter Study. Fertil Steril. 1995;64(5):917\u201323.","journal-title":"Fertil Steril"},{"issue":"4","key":"3004_CR53","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00404-016-4163-1","volume":"294","author":"XF Du","year":"2016","unstructured":"Du XF, Yang XH, Li J, Hao M, Guo YH. Growth hormone co-treatment within a GnRH agonist long protocol improves implantation and pregnancy rates in patients undergoing IVF-ET. Arch Gynecol Obstet. 2016;294(4):877\u201383.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"3004_CR54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10815-008-9208-3","volume":"25","author":"JK de Prada","year":"2008","unstructured":"de Prada JK, VandeVoort CA. Growth hormone and in vitro maturation of rhesus macaque oocytes and subsequent embryo development. J Assist Reprod Genet. 2008;25(4):145\u201358.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"3004_CR55","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1210\/endo.135.5.7525255","volume":"135","author":"SY Chun","year":"1994","unstructured":"Chun SY, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJ. Gonadotropin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous insulin-like growth factor I. Endocrinology. 1994;135(5):1845\u201353.","journal-title":"Endocrinology"},{"issue":"7","key":"3004_CR56","first-page":"903","volume":"10","author":"J Baker","year":"1996","unstructured":"Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10(7):903\u201318.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"3004_CR57","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.fertnstert.2018.08.018","volume":"110","author":"SLP Regan","year":"2018","unstructured":"Regan SLP, Knight PG, Yovich JL, Arfuso F, Dharmarajan A. Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes. Fertil Steril. 2018;110(7):1298\u2013310.","journal-title":"Fertil Steril"},{"issue":"6","key":"3004_CR58","doi-asserted-by":"publisher","first-page":"e1005241","DOI":"10.1371\/journal.pgen.1005241","volume":"11","author":"E Fragouli","year":"2015","unstructured":"Fragouli E, Spath K, Alfarawati S, Kaper F, Craig A, Michel CE, et al. Altered levels of mitochondrial DNA are associated with female age, aneuploidy, and provide an independent measure of embryonic implantation potential. PLoS Genet. 2015;11(6):e1005241.","journal-title":"PLoS Genet"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-020-03004-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03004-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:19:08Z","timestamp":1621495148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03004-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3004"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03004-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Chongqing Health Center for Women and Children. In accordance with the measures of the People\u2019s Republic of China on the administration of Human Assisted Reproductive Technology, the ethical principles of the Human Assisted Reproductive Technology as well as the Helsinki declaration. In addition, written and informed consent was obtained from each participant that accepted the use of adjuvants, and they were required to pay for these adjuvants over and above the IVF treatment charges.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}